Fertility and Sterility
Volume 92, Issue 6 , Pages 1803-1810 , December 2009

Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome

  • José Bellver, M.D.

      Affiliations

    • Corresponding Author InformationReprint requests: José Bellver, M.D., Instituto Valenciano de Infertilidad, Plaza de la Policía Local 3, 46015, Valencia, Spain (FAX: 34-963050999).
    • ,
  • Antonio Pellicer, M.D.

Received 20 December 2008 ,Revised 8 April 2009 ,Accepted 16 June 2009.

References 

  1. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. Guidelines for referral and management of systemic lupus erythematosus in adults. Arthritis Rheum. 1999;42:1785–1796
  2. Madhok R, Wu O. Systemic lupus erythematosus. Am Pham Physician. 2007;76:1351–1353
  3. Geva E, Lerner-Geva L, Burke M, Vardinon N, Lessing JB, Amit A. Undiagnosed systemic lupus erythematosus in a cohort of infertile women. Am J Reprod Immunol. 2004;51:336–340
  4. Mackillop LH, Germain SJ, Nelson-Piercy C. Systemic lupus erythematosus. BMJ. 2007;335:933–936
  5. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008;358:929–939
  6. Askanase AD. Estrogen therapy in systemic lupus erythematosus. Treat Endocrinol. 2004;3:19–26
  7. Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med. 2005;142:953–962
  8. Yocum MW, Grossman J, Waterhouse C, Abraham GN, May AG, Condemi JJ. Monozygotic twins discordant for systemic lupus erythematosus. Arthritis Rheum. 1975;18:193–199
  9. Sullivan KE. Genetics of systemic lupus erythematosus: clinical implications. Rheum Dis Clin North Am. 2000;26:229–256
  10. Wakeland EK, Liu K, Graham RR, Behrens TW. Delineating the genetic basis of systemic lupus erythematosus. Immunity. 2001;15:397–408
  11. Namjou B, Kelly JA, Harley JB. The genetics of lupus. In:  Tsokos GC,  Gordon C,  Smolen JS editor. Systemic lupus erythematosus. Philadelphia: Mosby Elsevier; 2007;p. 74–80
  12. James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJ, Harley JB. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest. 1997;100:3019–3026
  13. Katsifis GE, Tzioufas AG. Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide. Lupus. 2004;13:673–678
  14. Gougeon A. The biological aspects of risks of infertility due to age: the female side. Rev Epidemiol Sante Republique. 2005;53:S37–S45
  15. Raptopoulou A, Sidiropoulos P, Boumpas DT. Ovarian failure and strategies for fertility preservation in patients with systemic lupus erythematosus. Lupus. 2004;13:887–890
  16. Janssen NM, Genta MS. The effects of immunopressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med. 2000;160:610–619
  17. Blumemfeld Z, Shapiro D, Shteinberg M, Avivi I, Nahir M. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy. Lupus. 2000;9:401–405
  18. Somers EC, Marder W, Christman GM, Ognenovski V, McCune WJ. Use of gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus. Arthritis Rheum. 2005;52:2761–2767
  19. Blumemfeld Z. GnRH-agonists in fertility preservation. Curr Opin Endocrinol Diabetes Obes. 2008;15:523–528
  20. Baker WF, Bick RL. The clinical spectrum of antiphospholipid syndrome. Hematol Oncol Clin N Am. 2008;22:33–52
  21. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306
  22. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999;42:1309–1311
  23. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46:1019–1027
  24. Gezer S. Antiphospholipid syndrome. Dis Mon. 2003;49:696–741
  25. Lockshin MD. Autoimmunity, infertility and assisted reproductive technologies. Lupus. 2004;13:669–672
  26. Mecacci F, Pieralli A, Bianchi B, Paidas MJ. The impact of autoimmune disorders and adverse pregnancy outcome. Semin Perinatol. 2007;31:223–226
  27. Bertsias G, Ionnadis JPA, Boletis J, Bombardieri S, Cervera R, Dostal C, et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for international clinical studies including therapeutics. Ann Rheum Dis. 2008;67:195–205
  28. Huong LT, Wechsler B, Piette JC. Induction d'ovulation et lupus. Ann Med Interne. 2003;154:45–50
  29. Carp HJ, Shoenfeld Y. Antiphospholipid antibodies and infertility. Clin Rev Allergy Immunol. 2007;32:159–161
  30. Stern C, Chamley L, Hale L, Kloss M, Speirs A, Baker HW. Antibodies to beta2 glycoprotein I are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence study. Fertil Steril. 1998;70:938–944
  31. Cervera R, Balasch J. Bidirectional effects on autoimmunity and reproduction. Hum Reprod Update. 2008;14:359–366
  32. Bellver J, Soares SR, Alvarez J, Muñoz E, Ramírez A, Rubio C, et al. The role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion. Hum Reprod. 2008;23:278–284
  33. Horstein MD, Davis OK, Massey JB, Paulson RJ, Collins JA. Antiphospholipid antibodies and in vitro fertilization success: a meta-analysis. Fertil Steril. 2000;73:330–333
  34. Backos M, Rai R, Regan L. Antiphospholipid antibodies and infertility. Hum Fertil. 2002;5:30–34
  35. The Practice Committee of the American Society for Reproductive Medicine . Anti-phospholipid antibodies do not affect IVF success. Fertil Steril. 2006;86:S224–S225
  36. Askanase AD, Buyon JP. Reproductive health in SLE. Best Pract Res Clin Rheumatol. 2002;16:265–280
  37. Shulman A. Safety of IVF under anticoagulant therapy in patients at risk for thrombo-embolic events. Reprod Biomed Online. 2006;12:354–358
  38. Ben-Chetrit A, Ben-Chetrit E. Systemic lupus erythematosus induced by ovulation induction treatment. Arthritis Rheum. 1994;37:1614–1617
  39. Casoli P, Tumiati B, La Sala G. Fatal exacerbation of systemic lupus erythematosus after induction of ovulation. J Rheumatol. 1997;24:1639–1640
  40. Huong DLT, Wechsler B, Piette JC, Arfi S, Gallinari C, Darbois Y, et al. Risks of ovulation-induction therapy in systemic lupus erythematosus. Br J Rheumatol. 1996;35:1184–1186
  41. Chan WS, Dixon ME. The “ART” of thromboembolism: a review of assisted reproductive technology and thromboembolic complications. Thromb Res. 2008;121:713–726
  42. Koo EJ, Rha JH, Lee BI, Kim MO, Ha CK. A case of cerebral infarct in combined antiphospholipid antibody and ovarian hyperstimulation syndrome. J Korean Med Sci. 2002;17:574–576
  43. Giner V, Oltra MR, Esteban MJ, García-Fuster MJ, Salvador A, Núñez J, et al. Catastrophic antiphospholipid syndrome related to severe ovarian hyperstimulation. Clin Rheumatol. 2007;26:991–993
  44. Andrejevic S, Bonaci-Nikolic B, Bukilica M, Macut D, Miljic P, Pavlovic M, et al. Intracardiac thrombosis and fever possibly triggered by ovulation induction in a patient with antiphospholipid syndrome. Scand J Rheumatol. 2002;31:249–251
  45. Girolami A, Scandellari R, Tezza F, Paternoster D, Girolami B. Arterial thrombosis in young women after ovarian stimulation: case report and review of the literature. J Thromb Thrombolysis. 2007;24:169–174
  46. Udoff LC, Branch DW. Management of patients with antiphospholipid antibodies undergoing in vitro fertilization. J Autoimmun. 2000;15:209–211
  47. Guballa N, Sammaritano L, Schwartzman S, Buyon J, Lockshin MD. Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum. 2000;43:550–556
  48. Aune B, Hoie KE, Oian P, Holst N, Osterud B. Does ovarian stimulation for in-vitro fertilization induce a hypercoagulable state?. Hum Reprod. 1991;6:925–927
  49. Kim HC, Kemmann F, Shelden RM, Saidi P. Response of blood coagulation parameters to elevated endogenous 17β estradiol levels induced by menopausal gonadotropins. Am J Obstet Gynecol. 1981;140:807–810
  50. Todorow S, Schricker ST, Siebzehpruebl ER, Neidhardt B, Wildt L, Lang N. Von Willebrand factor: an endothelial marker to monitor in vitro fertilization patients with ovarian hyperstimulation syndrome. Hum Reprod. 1993;8:2039–2046
  51. Sanchez-Guerrero J, Karlson EW, Liang MH, Hunter DJ, Speizer FE, Colditz GA. Past use of oral contraceptives and the risk of developing systemic lupus erythematosus. Arthritis Rheum. 1997;40:804–808
  52. Jungers P, Dougados M, Pelissier C, Kuttenn F, Tron F, Lesavre P, et al. Influence of oral contraceptive therapy on activity of systemic lupus erythematosus. Arthritis Rheum. 1982;25:618–623
  53. Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005;353:2550–2558
  54. Sánchez-Guerrero J, Uribe AG, Jiménez-Santana L, Mestanza-Peralta M, Lara-Reyes P, Seuc AH, et al. A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med. 2005;353:2539–2549
  55. Samsioe G. Coagulation and anticoagulation effects of contraceptive steroids. Am J Obstet Gynecol. 1994;170:1523–1527
  56. Lowe GDO. Common risk factors for both arterial and venous thrombosis. Br J Haematol. 2008;140:488–495
  57. Beller FK, Ebert C. Effects of oral contraceptives on blood coagulation: a review. Obstet Gynecol Surv. 1985;40:425–436
  58. Huong DLT, Wechsler B, Vauthier-Brouzes D, Duhaut P, Costedoat N, Lefebvre G, et al. Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles. Semin Artritis Rheum. 2002;32:174–188
  59. Ricci G, Cerneca F, Simeone R, Pozzobon C, Guarnieri S, Sartore A, et al. Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial. Hum Reprod. 2004;19:838–848
  60. Alvarez C, Marti-Bonmati L, Novella-Maestre E, Sanz R, Gomez R, Fernandez-Sanchez M, et al. Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction. J Clin Endocrinol Metab. 2007;92:2931–2937
  61. Mathur R, Kailasam C, Jenkins J. Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome. Hum Fertil (Camb). 2007;10:75–85
  62. Papanikolaou EG, Tournaye H, Verpoest W, Camus M, Vernaeve V, van Steirteghem A, et al. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod. 2005;20:636–641
  63. Blumemfeld Z. Treatment with gonadotropins-releasing hormone agonists and prevention of multiple gestations in lupus or antiphospholipid syndrome patients undergoing in vitro fertilization: comment on the article by Guballa et al. [Letter]. Arthritis Rheum. 2002;46:2542
  64. Lockshin MD, Sanmaritano LR. Lupus pregnancy. Autoimmunity. 2003;36:33–40
  65. Schwartz J, Freeman R, Frishman W. Clinical pharmacology or estrogens: cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women. J Clin Pharmacol. 1995;35:314–329
  66. Gompel A, Piette JC. Systemic lupus erythematosus and hormone replacement therapy. Menopause Int. 2007;13:65–70
  67. Carmona F, Font J, Cervera R, Muñoz F, Cararach V, Balasch J. Obstetrical outcome of pregnancy in patients with systemic lupus erythematosus. A study of 60 cases. Eur J Obstet Gynecol. 1999;83:137–142
  68. Moroni G, Ponticelli C. The risk of pregnancy in patients with lupus nephritis. J Nephrol. 2003;16:161–167
  69. Stratta P, Canavese C, Quaglia M. Pregnancy in patients with kidney disease. J Nephrol. 2006;19:135–143
  70. Branch WD, Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol. 2003;10:1333–1344
  71. D'Cruz DP. Systemic lupus erythematosus. BMJ. 2006;332:890–894

 Edward E. Wallach, M.D.Associate Editor

 J.B. has nothing to disclose. A.P. has nothing to disclose.

PII: S0015-0282(09)01354-5

doi: 10.1016/j.fertnstert.2009.06.033

Fertility and Sterility
Volume 92, Issue 6 , Pages 1803-1810 , December 2009

Article Tools